
A real-world study found evolocumab cut fatal or nonfatal heart attack risk 20% vs ezetimibe in adults with ASCVD and prior statin use.
by John C. Anders, AAI International With the advent of proteomics, innovative protein-based pharmaceuticals are entering the drug development pipeline. Compositional analysis, protein quantitation, and absorptivity determination by amino acid analysis ensures accurate characterization of recombinant proteins, amino acids, and peptides in development, bulk, and final products.
over 24 years ago
Analytical Advances: Paperless or Less Paper?over 24 years ago
Beyond QSITover 24 years ago
Determining Protein Concentration, Part 1: Methodologyover 24 years ago
Guest Editorial: The Protein Production Challengeover 24 years ago
Business Matters: Personalized Medicine or Blockbusterology?





